A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)

Clinical trial NCT06630234 · RECRUITING

Trial details

NCT number: NCT06630234
Sponsor: Deciphera Pharmaceuticals, LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumor (GIST)

Start date: 2024-12-10
Primary completion: 2028-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.